Ressources

Bienvenue dans notre banque interrogeable de ressources et de documentation sur l’approvisionnement plus sécuritaire et autres sujets connexes.

 

 

Evaluation of an emergency safe supply drugs and managed alcohol program in COVID-19 isolation hotel shelters for people experiencing homelessness

During a COVID-19 outbreak in the congregate shelter system in Halifax, Nova Scotia, Canada, a multidisciplinary health care team provided an emergency “safe supply” of pharmaceutical-grade medicat

Original research | 2022
Harm reduction, Policy/Regulatory, Safer supply, About PWUD, Social services, Outcomes, Poverty, Housing, Small/medium cities

Getting to Tomorrow

Video | 2020
Overdose, Mortality, Policy/Regulatory, Decriminalization/legalization, Equity, Advocacy, About prescribers, About PWUD, Illegal drugs

Perceptions and experiences toward extended-release buprenorphine among persons leaving jail with opioid use disorders before and during COVID-19: an in-depth qualitative study

This study explores the experiences of adults receiving extended-release buprenorphine (XRB) as a jail-to-community treatment.
Original research | 2022
About PWUD, Barriers and enablers, Legal system/law enforcement, Substitution/OAT

Racial/ethnic disparities in the availability of hospital based opioid use disorder treatment

This study examines the relationship between hospital-based or initiated OUD services and the racial/ethnic composition of the surrounding community.
Original research | 2022
Equity, About PWUD, Illegal drugs, Substitution/OAT, Transitions in care/treatment, Hospitals

Safer Crack Smoking

Handout | 2020
Harm reduction, Illegal drugs, Stimulants

Safer Crystal Meth Smoking

Handout | 2020
Harm reduction, Illegal drugs, Stimulants

Screening in Trauma for Opioid Misuse Prevention (STOMP): Results from a prospective cohort of victims of traumatic injury

Traumatic injury frequently requires opioid analgesia to manage pain and avoid catastrophic complications. Risk screening for opioid misuse and the development of use disorder remains uninvestigated
Original research | 2022
Harm reduction, Hesitancy of prescribers , About PWUD, Outcomes, Chronic pain, Mental health, Hospitals

The COVID-19 pandemic and opioid use disorder: Expanding treatment with buprenorphine, and combining safety precautions with telehealt

This study investigated the efficacy and safety of providing medication for opioid use disorder (MOUD) and individualized telehealth in Kentucky, a state severely impacted simultaneously by the opioid
Original research | 2022
About PWUD, Barriers and enablers, Outcomes, Poverty, Housing, Illegal drugs, Substitution/OAT, Digital health

The impact of an easy access drug supply management policy law on the consumption and abuse of opioids in Catalonia: A population-based study

In 2012, Spain adopted new legislation on opioid prescription (the ROE law), which meant that practitioners no longer needed to obtain extra authorisation in order to prescribe strong opioids.
Original research | 2021
Evidence base, Policy/Regulatory, Safer supply, About prescribers, Outcomes

The role of cannabis in pain management among people living with HIV who use drugs: A qualitative study

Recent research suggests people living with HIV use cannabis for pain relief, including as an adjunct to opioids.
Original research | 2021
Decriminalization/legalization, Equity, About PWUD, Outcomes, Illegal drugs, Chronic pain

Trends in opioid-related crime incidents and comparison with opioid overdose outcomes in the United States

Our objective is to understand temporal trends in opioid-related crime incidents and the comparability with the dynamic patterns in health-related outcomes.
Original research | 2022
About PWUD, Crime, Illegal drugs

Unequal access to opioid agonist treatment and sterile injecting equipment among hospitalized patients with injection drug use-associated infective endocarditis

Among hospitalized patients with injection drug use-associated infective endocarditis (IDU-IE) at the two tertiary-care hospitals in the Canadian Maritimes, we aimed to identify (1) the availability o
Original research | 2022
Wrap-around services, About prescribers, Outcomes, Illegal drugs, Small/medium cities, Substitution/OAT, Transitions in care/treatment, Hospitals

Validation of the tobacco, alcohol, prescription medication, and other substance use (TAPS) tool with the WHO alcohol, smoking, and substance Involvement screening test

The goal of this study was to validate the performance of the Tobacco, Alcohol, Prescription medication, and other Substance use (TAPS) tool in community pharmacy settings compared to a reference-stan
Original research | 2021
About pharmacists, Illegal drugs, Stimulants

"You're Always Jumping Through Hoops": Journey Mapping the Care Experiences of Individuals With Opioid Use Disorder-associated Endocarditis

Individuals with OUD-associated endocarditis require long periods of complex medical care, often face recurrent addiction- and infection-related complications, and have dismal clinical outcomes.
Original research | 2020
About PWUD, Barriers and enablers, Illegal drugs, Substitution/OAT, Injecting drugs, Stigma, Hospitals

A Guide to Staying Off Crystal for a Day or Longer: Practical tips from gay and bisexual men

Includes harm reduction tips
Handout | 2013
Withdrawal, Harm reduction, About PWUD, Illegal drugs, 2SLGBTQI+, Stimulants, Sex/Gender

Best Practices for Health and Social Service Providers Working with People Who Use Drugs

Short visual summary of Blood Ties' "Don't Be An A**hole" best practices report
Infographic | 2018
Clinical guidance, Wrap-around services, Equity, About prescribers, About PWUD, Social services, Barriers and enablers, Indigenous, Small/medium cities, Stigma

Changes in methadone take-home dosing before and after COVID-19

We assessed the adoption of increased take-home medication during COVID-19 and whether increased take-home doses is associated with clients' characteristics.

Original research | 2022
Policy/Regulatory, About PWUD, Illegal drugs, Substitution/OAT, Carries/take-home doses

Crystal methamphetamine use subgroups and associated addiction care access and overdose risk in a Canadian urban setting

Subgroups within the diverse methamphetamine-using population may have distinct treatment needs.
Original research | 2022
Overdose, Harm reduction, Equity, About PWUD, Outcomes, Poverty, Illegal drugs, Stimulants

Don't Be An A**hole: Best Practices for Health and Social Service Providers Working with People Who Use Drugs

Outlines key themes found among people who use drugs about their experiences with various health and social service agencies and providers in Whitehorse
Report | 2018
Clinical guidance, Wrap-around services, Equity, About prescribers, About PWUD, Social services, Barriers and enablers, Indigenous, Small/medium cities, Stigma

Illicit Drug Toxicity Deaths in BC January 1 2012 - July 31 2022

This report summarizes all unintentional illicit drug toxicity deaths in British Columbia (accidental and undetermined) that occurred between

Report | 2022
Overdose, Mortality, Evidence base, Safer supply, About PWUD, Outcomes, Illegal drugs, Small/medium cities, Sex/Gender

Affiner votre recherche

Mots clés
Format
Région